Atlas Trials

Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer

Clinical trial NCT03926091 · UNKNOWN

Trial details

NCT number
NCT03926091
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2019-04-01
Primary completion
2024-11-01
Enrollment
2172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.